Aaron S. Kesselheim M.D. J.D. M.P.H.
Editor-in-Chief

Aaron S. Kesselheim
Harvard University Medical School
Aaron S. Kesselheim M.D. J.D. M.P.H. is a Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital. He is a primary care physician at the Phyllis Jen Center for Primary Care at Brigham and Women’s Hospital. Within the Division, Aaron created and helps lead the Program On Regulation, Therapeutics, And Law (PORTAL), an interdisciplinary research center focusing on intersections among prescription drugs and medical devices, patient health outcomes, and regulatory practices and the law. Author of over 700 publications in the peer-reviewed medical and health policy literatures, Aaron was recognized as one of the top 3 most cited health law scholars in the US from 2013-2020 in Web of Science, Westlaw, and GoogleScholar. At the HMS Center for Bioethics, Aaron co-teaches a course on health policy, law, and bioethics and organizes a policy and ethics seminar series. Aaron also serves as a Visiting Professor of Law at Yale Law School, where he teaches a yearly course on Food and Drug Administration Law and Policy, which is also offered at the Yale School of Public Health. In 2020, he was elected to the National Academy of Medicine. He has been the editor-in-chief of the Journal of Law, Medicine, and Ethics since 2017.